Lahore: Punjab health authorities have announced an antibiotic ban after laboratory tests found certain batches of medicines unsafe for public use.
The latest antibiotic ban followed officials’ discovery that an antibiotic used for bacterial infections failed quality standards during an inspection. Authorities said the affected medicines could create serious health risks for patients.
According to the Punjab Drug Control Department, inspectors identified several batches of substandard medicines during routine testing. As a result, officials immediately ordered pharmacies and medical stores to stop selling the affected products.
Meanwhile, authorities also found contamination in water prepared for injections. Officials warned that contaminated injection products can expose patients to dangerous infections and severe medical complications.
In addition, the antibiotic used for bacterial infection treatment also failed the laboratory evaluation. The Drug Regulatory Authority of Pakistan stated that the medicine may cause bloodstream infections instead of helping patients recover safely.
Therefore, the antibiotic ban now applies to the identified batches distributed in different parts of Punjab and other cities, including Lahore and Karachi. Officials said some pharmaceutical companies manufactured the affected products locally.
Furthermore, drug inspectors have started checking pharmacies and medical stores to ensure full compliance with the antibiotic ban orders. Authorities instructed store owners to remove the affected medicines from shelves immediately and return them to suppliers.
Health experts have also urged the public to remain careful while purchasing medicines. They advised patients to avoid using antibiotics without proper medical guidance.
At the same time, doctors warned against self-medication. They said unsafe medicines can create severe complications, especially for patients already dealing with infections or weak immune systems.
The antibiotic ban has also raised concerns among healthcare professionals about the quality control in the pharmaceutical sector. Experts believe stricter monitoring can help prevent similar incidents in the future.
Moreover, officials confirmed that investigations remain underway. Authorities promised strict legal action against companies that produce or distribute unsafe medicines.
For now, the antibiotic ban will remain in place until regulators complete further testing and safety checks. Meanwhile, citizens have been encouraged to consult certified doctors or pharmacists before using any injectable medicine or antibiotic product.
